Key result
Simultaneous four-valve transcatheter replacement achieves successful valve function and thrombus resolution at 15 months.
Case Report (n=1)
This is the first reported case demonstrating the feasibility and 15-month success of simultaneous fully percutaneous transcatheter replacement of all four cardiac valves.
Highlights risk of simultaneous triple bioprosthetic failure at 13 years; leaves open optimal surveillance and reintervention strategies.
A 58-year-old woman with rheumatic heart disease and triple bioprosthetic valve replacement (aortic, mitral, tricuspid; 2011) presented with one year of worsening dyspnoea, chest tightness, and palpitations. Thirteen years after surgery, she exhibited NYHA III heart failure, irregular rhythm, and biphasic murmur. Echocardiography revealed advanced degeneration with severe stenosis and regurgitation of all prostheses, pulmonary valve regurgitation, right atrial thrombus (4.4 × 2.8 cm), biatrial enlargement, and biventricular dysfunction (LVEF 32%, RVEF 19%, FAC 26%). A fully percutaneous procedure was performed, sequentially deploying a balloon expandable PrizValve 23# in the aortic, PrizValve 26# in the mitral, PrizValve 29# in the tricuspid, and a self-expanding PT-Valve 40/26 in the pulmonary position. An iatrogenic atrial septal defect created during the procedure was closed to prevent paradoxical embolism (Panels A and B). Postoperatively, warfarin maintained the international normalized ratio between 2 and 3. At 15 months, all valves functioned well with thrombus resolution (Panels C and D). This is the first reported case of simultaneous transcatheter replacement of all four valves. Panel A: Immediate postoperative fluoroscopy demonstrated four transcatheter valves and closure of an iatrogenic atrial septal defect with an occluder. Panel B: CT after implantation of four valves and iatrogenic atrial septal defect closure. Panel C: Echocardiographic short axis view of the great arteries demonstrated no regurgitation of the implanted aortic and pulmonary valves and no flow acceleration across the pulmonary valve. Panel D: Echocardiographic apical four chamber view demonstrated no regurgitation of the implanted mitral and tricuspid valves. Supplementary data are not available at European Heart Journal online. All authors declare no disclosure of interest for this contribution. The data that support the findings of this study are available from the corresponding author upon reasonable request. No funding.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) conducted a case report in Rheumatic heart disease with degenerated triple bioprosthetic valves and heart failure (n=1). Simultaneous transcatheter replacement of four cardiac valves was evaluated on Valve function and clinical status at follow-up. Simultaneous transcatheter replacement of all four cardiac valves was successfully performed, with all valves functioning well and thrombus resolution at 15 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: